PCPC3 is pleased to announce that its entire membership has reviewed and is highly supportive of the most recent version of the National Comprehensive Cancer Network’s (NCCN’s) new guidelines for patients on the diagnosis and treatment of prostate cancer.
The new guidelines were most recently updated and re-issued by the NCCN Foundation early in 2015. While there are now many books available on the diagnosis and management of prostate cancer, such resources are rarely updated on a frequent and regular basis. By contrast, the NCCN patient guidelines are updated regularly and thus offer patients a sound and current introduction to the basics of prostate cancer diagnosis and its management, based on the stage, grade, and risk level of the cancer.
The complete NCCN patient guidelines are available to patients on line at no cost via the NCCN web site. The available resources include:
- The complete 104-page booklet for patients and family members
- A summary of recent updates to the guidelines
- A video library and
- An NCCN Quick Guide™ to important issues addressed in the guidelines themselves
This set of resources can offer the newly diagnosed patient — or the patient with progressive prostate cancer — a straightforward and sound introduction to the key issues relevant to the management of his prostate cancer.
PCPC3 — the patient-centered prostate cancer collaborative coalition — is a group of independent, not-for-profit, patient-centric organizations whose primary goals include the education and support of men diagnosed with prostate cancer, their family members and care-givers, and all men at risk for prostate cancer. For more information about PCPC3, please see the PCPC3 web site.